| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |